密尔克卫：2024年资本开支预计5亿持续拓展复配分装业务

作者：李佳晅文章来源：亿邦动力

2024-08-06 10:49

作者：李佳晅文章来源：亿邦动力

2024-08-06 10:49

邦小白快读

全文速览

密尔克卫作为化工供应链服务商，2024年业务表现强劲，未来计划明确，重点信息包括财务数据和实操策略。

1. 公司主营化工危险品物流、仓储及交易服务，2024年中报显示收入59.92亿元同比增32.35%，归母净利润3.11亿元增22.74%，负债率60.99%，显示稳健增长。

2. 资本开支预计5亿元，用于自建仓库基地和并购，实操干货包括通过剥离高风险大宗商品业务（如煤炭）避免坏账风险，专注于物贸一体化产品。

3. 复配分装业务亮点：自建仓库具备能力，通过收购广州密尔克卫宝会新材料有限公司和广州捷晟强化服务，张家港基地年底投入使用，提供可操作的分装策略。

密尔克卫的业务拓展涉及化工品产业链，对品牌渠道建设和产品研发有启示，重点关注复配分装能力。

1. 品牌渠道建设：公司通过并购整合资源（如广州宝会和广州捷晟），夯实化学品分销网络，显示渠道合作模式。

2. 产品研发：复配分装业务强化实验室研发能力，张家港基地建设提供新产品设计平台，支持化工品创新。

3. 消费趋势和用户行为：财务数据（收入增32.35%）反映化工市场增长，用户需求转向物贸一体化产品（如黄磷和特种化工品），提示品牌商关注供应链整合机会。

密尔克卫的业绩增长和市场机会提供可学习点，风险控制措施值得借鉴，重点关注政策应对和合作方式。

1. 增长市场：2024年中报收入同比增42.15%（第二季度），显示化工供应链扩张机会，复配分装业务成为新增长点。

2. 风险提示和应对措施：剥离大宗商品业务（如煤炭）规避坏账风险，卖家可学习此策略管理库存风险。

3. 合作方式和机会提示：资本开支5亿元用于并购和自建仓库，提供招商合作机会；最新商业模式包括物贸一体化，卖家可探索类似分销模式。

密尔克卫的复配分装业务和供应链整合启示产品生产需求，提供商业机会和数字化推进方向。

1. 产品生产和设计需求：复配分装能力强化化学品加工（如通过收购广州宝会），张家港基地年底启用，支持工厂定制化生产需求。

2. 商业机会：公司收入增长32.35%反映化工市场潜力，工厂可合作开发物贸一体化产品（如黄磷），拓展分销渠道。

3. 推进数字化和电商启示：并购整合（如广州捷晟）显示数字化供应链管理，工厂可借鉴此模式优化生产流程。

密尔克卫的行业趋势和解决方案聚焦化工供应链，客户痛点如风险控制得到有效应对。

1. 行业发展趋势：公司拓展复配分装业务和并购（广州宝会等），显示化工供应链整合趋势，服务商可关注此方向。

2. 新技术和客户痛点：复配分装能力强化实验室研发，解决化学品加工痛点；剥离大宗商品业务规避坏账风险，提供风险管理解决方案。

3. 解决方案：资本开支5亿元用于自建仓库，服务商可参考此基础设施投资，优化物流服务。

密尔克卫的平台运营涉及招商和风险规避，资本开支和业务模式提供管理启示。

1. 平台招商和运营管理：资本开支5亿元用于并购和自建仓库，显示平台扩张策略，平台商可学习此招商模式整合资源。

2. 商业需求和问题：公司剥离高风险大宗业务，规避坏账风险，平台商需关注类似风向规避。

3. 平台最新做法：复配分装业务通过收购强化服务能力（如广州密尔克卫宝会），提供运营管理范例，支持平台服务升级。

密尔克卫的商业模式和产业动向提供研究价值，财务数据支持新问题分析。

1. 产业新动向：公司拓展复配分装业务（张家港基地年底启用）和并购整合，显示化工供应链向增值服务转型。

2. 新问题和商业模式：剥离大宗商品业务避免坏账风险，启示风险控制策略；物贸一体化模式（如黄磷产品）作为创新商业模式。

3. 政策法规启示和财务数据：收入增32.35%、利润增22.74%支持可持续增长分析，负债率60.99%提示财务风险管理，研究者可探讨政策优化建议。

声明：快读内容全程由AI生成，请注意甄别信息。如您发现问题，请发送邮件至 run@ebrun.com 。

我是品牌商卖家工厂服务商平台商研究者帮我再读一遍。

Quick Summary

As a chemical supply chain service provider, Milkilog demonstrated strong performance in 2024 with clear future plans, focusing on financial data and practical strategies.

1. The company specializes in hazardous chemical logistics, warehousing, and trading. Its 2024 interim report shows revenue of RMB 5.992 billion, up 32.35% YoY, net profit of RMB 311 million, up 22.74% YoY, and a debt-to-asset ratio of 60.99%, indicating stable growth.

2. Capital expenditure is projected at RMB 500 million for self-built warehouses and acquisitions. Practical strategies include divesting high-risk bulk commodity businesses (e.g., coal) to avoid bad debt risks and focusing on integrated logistics-trading products.

3. Blending and repackaging business highlights: Self-built warehouses enhance capabilities, acquisitions like Guangzhou Milkilog Baohui New Materials and Guangzhou Jiesheng strengthen services, and the Zhangjiagang base will be operational by year-end, providing actionable repackaging strategies.

Milkilog's business expansion in the chemical industry chain offers insights for brand channel development and product R&D, with a focus on blending and repackaging capabilities.

1. Brand channel building: The company consolidates resources through acquisitions (e.g., Guangzhou Baohui and Jiesheng), strengthening its chemical distribution network and demonstrating partnership models.

2. Product R&D: Blending and repackaging operations enhance lab R&D capabilities, while the Zhangjiagang base provides a platform for new product design, supporting chemical innovation.

3. Consumer trends and user behavior: Financial data (32.35% revenue growth) reflects chemical market expansion, with demand shifting toward integrated logistics-trading products (e.g., yellow phosphorus and specialty chemicals), suggesting brands explore supply chain integration opportunities.

Milkilog's growth and market opportunities offer learnings, with risk control measures worth emulating, particularly in policy adaptation and collaboration models.

1. Growth markets: Q2 2024 interim revenue surged 42.15% YoY, indicating expansion opportunities in chemical supply chains, with blending and repackaging as a new growth driver.

2. Risk mitigation: Divesting bulk commodity businesses (e.g., coal) avoids bad debt risks, a strategy sellers can adopt for inventory management.

3. Collaboration opportunities: RMB 500 million capital expenditure for acquisitions and self-built warehouses opens partnership avenues; the integrated logistics-trading model provides a template for distributors.

Milkilog's blending/repackaging operations and supply chain integration insights inform production needs, offering business opportunities and digitalization directions.

1. Production and design demands: Blending/repackaging capabilities enhance chemical processing (e.g., via Guangzhou Baohui acquisition), while the Zhangjiagang base supports customized production.

2. Business opportunities: 32.35% revenue growth reflects chemical market potential; factories can collaborate on integrated products (e.g., yellow phosphorus) to expand distribution.

3. Digitalization insights: Acquisitions (e.g., Guangzhou Jiesheng) demonstrate digital supply chain management, a model factories can adopt to optimize processes.

Milkilog's industry trends and solutions focus on chemical supply chains, addressing client pain points like risk control effectively.

1. Industry trends: Expansion into blending/repackaging and acquisitions (e.g., Guangzhou Baohui) signal supply chain integration, a direction for service providers to monitor.

2. Technology and pain points: Blending/repackaging enhances lab R&D, solving chemical processing challenges; divesting bulk commodities mitigates bad debt risks, offering risk management solutions.

3. Solutions: RMB 500 million capital expenditure on self-built warehouses provides a reference for infrastructure investment to optimize logistics services.

Milkilog's platform operations involve partnership recruitment and risk avoidance, with capital expenditure and business models offering management insights.

1. Partnership and operations management: RMB 500 million capital expenditure for acquisitions and self-built warehouses reflects platform expansion strategies, a model for marketplace operators to emulate.

2. Business risks: Divesting high-risk bulk businesses avoids bad debt, highlighting similar risks marketplace sellers should address.

3. Latest practices: Blending/repackaging services strengthened via acquisitions (e.g., Guangzhou Milkilog Baohui) offer operational benchmarks for platform service upgrades.

Milkilog's business model and industry dynamics provide research value, with financial data supporting analysis of emerging issues.

1. Industry trends: Expansion into blending/repackaging (Zhangjiagang base operational by year-end) and M&A integration reflect a shift toward value-added services in chemical supply chains.

2. New business models: Divesting bulk commodities to avoid bad debt informs risk control strategies; integrated logistics-trading (e.g., yellow phosphorus) represents an innovative model.

3. Policy and financial insights: 32.35% revenue growth and 22.74% profit growth support sustainable growth analysis, while a 60.99% debt ratio highlights financial risk management, suggesting policy optimization avenues for researchers.

Disclaimer: The "Quick Summary" content is entirely generated by AI. Please exercise discretion when interpreting the information. For issues or corrections, please email run@ebrun.com .

I am a Brand Seller Factory Service Provider Marketplace Seller Researcher Read it again.

【亿邦原创】日前，密尔克卫（603713）发布公告称公司于2024年8月2日接受中欧基金管理有限公司、中银基金管理有限公司、兴证全球基金管理有限公司等76家机构调研，其中包括14家基金、20家券商、8家投资公司、2家保险公司、8家外资机构、6家其他机构。密尔克卫就公司目前的业务情况作出说明，并表示2024年公司的资本开支预计在5亿元左右，主要包括自建的仓库基地和可能的并购。

密尔克卫成立于1998年，是一家化工供应链服务商。主要从事化工危险品海空运国际集装箱、集装罐货运代理业务以及国内物流和仓储服务。公司客户主要为化工行业贸易商，密尔克卫负责从发货人处提取货物，组织国内和国际运输并分拨派送至收货人指定交货点。近年来公司还逐渐向化工品产业链上下游延伸，开拓化工品交易服务。2018年，密尔克卫公开发行3812万股A股在上交所上市，成为中国民营化工供应链主板上市第一股。

密尔克卫2024年中报显示，公司主营收入59.92亿元，同比上升32.35%；归母净利润3.11亿元，同比上升22.74%；扣非净利润2.87亿元，同比上升19.55%；其中2024年第二季度，公司单季度主营收入30.97亿元，同比上升42.15%；单季度归母净利润1.6亿元，同比上升9.58%；单季度扣非净利润1.47亿元，同比上升6.18%；负债率60.99%，投资收益454.01万元，财务费用6205.24万元，毛利率11.24%。

以下为调研问题摘要：

提问：一些大宗供应链企业会面临较高的坏账风险,公司是否有同样的情况?

回答：公司自2023年起对大宗商品相关的业务进行了梳理，剥离了不依托于公司综合的物流能力而开展的贸易品种，比如煤炭；选择符合公司物贸一体化逻辑的产品相关业务，比如黄磷和一些特种化工品。因此公司目前并不存在大宗商品分销板块的坏账风险敞口。

提问：公司预计今年的资本开支金额是多少?

回答：公司2024年的资本开支预计在5亿元左右，主要包括自建的仓库基地和可能的并购。

提问：公司在复配分装业务上有什么亮点?

回答：公司自建的危险品仓库部分拥有复配分装的能力；公司2023年收购的广州宝会树脂有限公司（现已更名为“广州密尔克卫宝会新材料有限公司”）、2024年收购的广州捷晟也都进一步夯实了化学品复配分销增值服务能力，使实验室研发及应用的能力持续强化巩固；此外，公司在张家港建设的复配分装基地有望于今年年底投入使用。